A carregar...

Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia

The application of nucleoside analogue-based chemotherapy and immunotherapy with rituximab or alemtuzumab has increased both response rate and survival in patients with Chronic Lymphocytic Leukemia (CLL). However, because none of these therapies is curative, sequential therapeutic regimens are requi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cortelezzi, Agostino, Sciumè, Mariarita, Reda, Gianluigi
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407617/
https://ncbi.nlm.nih.gov/pubmed/22851972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/393864
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!